CellFE grabs $3.6 mln

CellFE Inc, a developer of a microfluidics-based device to deliver gene-editing molecules, has raised $3.6 million in funding.

CellFE Inc, a developer of a microfluidics-based device to deliver gene-editing molecules, has raised $3.6 million in funding. Cota Capital and Dynamk Capital led the round with participation from Embark Ventures.

Source: Press Release